{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T04:52:01Z","timestamp":1768366321792,"version":"3.49.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Malignant pleural effusion due to metastatic squamous cell carcinoma is uncommon. Keratinizing squamous cell carcinoma is morphologically identifiable, whereas nonkeratinizing squamous cell carcinoma poses diagnostic challenges and is prone to underdiagnosis or misdiagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>This study reports the case of a 66-year-old East Asian man with a history of esophageal squamous cell carcinoma who developed pleural metastasis 3\u00a0years after chemotherapy, presenting with persistent, dull right-sided chest pain of unknown origin. Chest computed tomography revealed a large left pleural effusion with partial atelectasis. Approximately 600\u00a0ml of bloody fluid was drained via thoracentesis and catheter drainage. Cytological examination showed tumor cells exhibiting ring-like and pseudoglandular structure. The final cytological diagnosis was metastatic squamous cell carcinoma within the pleural effusion. The patient opted for symptomatic and conservative management and died 9\u00a0months after malignant pleural effusion diagnosis during follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>When metastatic squamous cell carcinoma in pleural effusion is poorly differentiated and exhibits atypical changes such as pseudoglandular and signet ring-like features, vigilance is required during serous fluid cytopathological diagnosis. An accurate diagnosis provides the basis for subsequent clinical treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13256-025-05510-w","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T14:46:20Z","timestamp":1764945980000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Malignant pleural effusion due to metastatic squamous cell carcinoma exhibiting pseudoglandular and signet ring-like features: a case report"],"prefix":"10.1186","volume":"20","author":[{"given":"Qing","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhirong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"issue":"3","key":"5510_CR1","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1159\/000501790","volume":"64","author":"M Puri","year":"2020","unstructured":"Puri M, Sen R, Gupta UP, et\u00a0al. DNA ploidy analysis and cell block immunohistochemistry in the diagnosis of malignant effusions. Acta Cytol. 2020;64(3):256\u201364.","journal-title":"Acta Cytol"},{"issue":"3","key":"5510_CR2","first-page":"292","volume":"33","author":"YX Sui","year":"2017","unstructured":"Sui YX, Liu Y, Jiang N, et\u00a0al. Immunohistochemical detection and molecular pathological examination of 142 cases of malignant pleural effusion. Chin J Clin Exp Pathol. 2017;33(3):292\u20136 (In Chinese).","journal-title":"Chin J Clin Exp Pathol"},{"key":"5510_CR3","first-page":"93","volume-title":"Non-gynecological exfoliative cytology","author":"CQ Zhao","year":"2016","unstructured":"Zhao CQ, Fan F, Shen RL, et\u00a0al. Non-gynecological exfoliative cytology. Beijing: Beijing Science and Technology Press; 2016. p. 93\u20135 (In Chinese)."},{"issue":"9","key":"5510_CR4","first-page":"1020","volume":"25","author":"RQ Li","year":"2016","unstructured":"Li RQ, Cao L, Zhao KL. Progress in diagnosis and treatment of local recurrence after radical radiotherapy for esophageal cancer. Chin J Radiat Oncol. 2016;25(9):1020\u20134 (In Chinese).","journal-title":"Chin J Radiat Oncol"},{"issue":"1","key":"5510_CR5","first-page":"40","volume":"46","author":"China Association of Health Promotion and Education","year":"2024","unstructured":"China Association of Health Promotion and Education, Cancer Rehabilitation and Palliative Treatment Professional Committee of China Anti-Cancer Association. Expert consensus on diagnosis and treatment of malignant pleural effusion caused by lung cancer. Chin J Oncol. 2024;46(1):40\u20137 (In Chinese).","journal-title":"Chin J Oncol"},{"issue":"5","key":"5510_CR6","first-page":"287","volume":"131","author":"L Wang","year":"2023","unstructured":"Wang L, Smith J, Patel R. Unusual cytomorphologies in malignant effusions: a multi-institutional study. Cancer Cytopathol. 2023;131(5):287\u201395.","journal-title":"Cancer Cytopathol"},{"issue":"7","key":"5510_CR7","first-page":"e45","volume":"18","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Chen X, Li H, et\u00a0al. Anti-PD1\/VEGF combination therapy for malignant pleural effusion control in advanced esophageal SCC: a phase II trial. J Thorac Oncol. 2023;18(7):e45\u201352.","journal-title":"J Thorac Oncol"},{"key":"5510_CR8","unstructured":"National comprehensive cancer network (NCCN). NCCN clinical practice guidelines in oncology: esophageal and esophagogastric junction cancers. Version 3.2024. Accessed May 1, 2024."},{"issue":"suppl 1","key":"5510_CR9","first-page":"S123","volume":"35","author":"EM O\u2019Reilly","year":"2024","unstructured":"O\u2019Reilly EM, Bang YJ. Tremelimumab plus olaparib in MPE from upper GI cancers: results from the ORION-2 trial [abstract LBA-5]. Ann Oncol. 2024;35(suppl 1):S123.","journal-title":"Ann Oncol"},{"issue":"4","key":"5510_CR10","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.chest.2023.04.036","volume":"164","author":"H Shao","year":"2023","unstructured":"Shao H, Kim DW, Park S, et\u00a0al. Cytomorphologic predictors of pleural recurrence after drainage in malignant effusions. Chest. 2023;164(4):892\u2013901.","journal-title":"Chest"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05510-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-025-05510-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05510-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:20:10Z","timestamp":1768342810000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13256-025-05510-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5510"],"URL":"https:\/\/doi.org\/10.1186\/s13256-025-05510-w","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective case report was conducted in accordance with the Declaration of Helsinki. Ethical approval was waived by the Institutional Review Board of Deyang People\u2019s Hospital as per national regulations for anonymized retrospective studies. Written informed consent was obtained from the patient\u2019s legal surrogate prior to inclusion.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s next-of-kin for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}